Juliette Berangere Audet, Chief Business Officer at NewAmsterdam Pharma Co N.V. (NAMS), bought 1,104 shares at $15.70 ($17K) on 2024-09-26, disclosed to the SEC on 2024-09-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.